24-Hour Intraocular Pressure (IOP) Control With Travoprost/Timolol Fixed Combination
Status:
Completed
Trial end date:
2007-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the short-term (8 week) mean 24-hour intraocular
pressure control and safety of TravTim fixed combination given once in the evening with
placebo once in the morning versus TravTim given once in the morning with placebo once in the
evening in patients with open-angle glaucoma.